Retour
59
Fourchette du Jour
35,67 €
37,15 €
Fourchette 52 Semaines
35,37 €
61,25 €
Volume
294 884
Moyenne 50J / 200J
41,25 €
/
46,56 €
Clôture Précédente
36,63 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 24,1 | 0,3 |
| P/B | 1,1 | 2,9 |
| ROE % | 4,7 | 3,7 |
| Net Margin % | 3,4 | 3,8 |
| Rev Growth 5Y % | 8,0 | 10,0 |
| D/E | 0,8 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
5,55 €
5,49 € – 5,62 €
|
1,5 B | 1 |
| FY2027 |
4,93 €
4,84 € – 5,09 €
|
1,4 B | 3 |
| FY2026 |
4,36 €
4,34 € – 4,38 €
|
1,4 B | 3 |
Points Clés
Revenue grew 8,00% annually over 5 years — modest growth
Earnings declined -64,47% over the past year
ROE of 4,72% is below average
Generating 150,88M in free cash flow
Cash machine — converts 320,65% of earnings into free cash flow
Capital efficient — spends only 1,44% of revenue on capex
Croissance
Revenue Growth (5Y)
8,00%
Revenue (1Y)5,18%
Earnings (1Y)-64,47%
FCF Growth (3Y)19,13%
Qualité
Return on Equity
4,72%
ROIC4,12%
Net Margin3,42%
Op. Margin7,46%
Sécurité
Debt / Equity
0,81
Current Ratio2,14
Interest Coverage3,30
Valorisation
P/E Ratio
24,06
P/B Ratio1,10
EV/EBITDA18,77
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,18% | Revenue Growth (3Y) | 5,09% |
| Earnings Growth (1Y) | -64,47% | Earnings Growth (3Y) | -14,56% |
| Revenue Growth (5Y) | 8,00% | Earnings Growth (5Y) | -6,87% |
| Profitability | |||
| Revenue (TTM) | 1,37B | Net Income (TTM) | 47,06M |
| ROE | 4,72% | ROA | 2,02% |
| Gross Margin | 54,59% | Operating Margin | 7,46% |
| Net Margin | 3,42% | Free Cash Flow (TTM) | 150,88M |
| ROIC | 4,12% | FCF Growth (3Y) | 19,13% |
| Safety | |||
| Debt / Equity | 0,81 | Current Ratio | 2,14 |
| Interest Coverage | 3,30 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 24,06 | P/B Ratio | 1,10 |
| P/S Ratio | 0,82 | PEG Ratio | -0,41 |
| EV/EBITDA | 18,77 | Dividend Yield | 0,02% |
| Market Cap | 1,13B | Enterprise Value | 1,93B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,37B | 1,31B | 1,24B | 1,05B | 1,01B |
| Net Income | 47,06M | 132,42M | 64,46M | -80,58M | 62,54M |
| EPS (Diluted) | 1,51 | 4,26 | 2,04 | -2,68 | 1,94 |
| Gross Profit | 750,48M | 733,03M | 676,25M | 571,25M | 568,04M |
| Operating Income | 102,62M | 200,33M | 120,60M | 70,05M | 109,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,33B | 2,31B | 2,30B | 2,30B | 1,77B |
| Total Liabilities | 1,29B | 1,34B | 1,47B | 1,55B | 980,58M |
| Shareholders' Equity | 1,03B | 962,68M | 834,22M | 745,55M | 785,44M |
| Total Debt | 834,94M | 905,78M | 991,25M | 1,05B | 684,66M |
| Cash & Equivalents | 40,82M | 24,46M | 24,30M | 28,94M | 20,85M |
| Current Assets | 672,86M | 640,01M | 615,65M | 581,23M | 460,12M |
| Current Liabilities | 315,04M | 278,13M | 310,73M | 296,55M | 196,65M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#236 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026